Skip to main content

Synthesis and Characterization of Phthalic Europium(III) Fluorescent Complex Nanorods

Buy Article:

$113.00 plus tax (Refund Policy)

Abstract:

The rare earth ion europium(III) was chosen as the central fluorescent ion, and phthalic acid (H2L) was chosen as the ligand. The rod-like phthalic europium(III) fluorescent complex was synthesized using a co-precipitation method in a polyvinylpyrrolidone (PVP) aqueous medium. The chemical composition of the synthesized complex was speculated to be PVP/Eu2L3·3H2O by elemental analysis, inductively coupled plasma-atomic emission spectroscopy (ICP-AES), and Fourier-transform infrared spectroscopy (FT-IR). The X-ray diffraction analytic (XRD) results indicated that the synthesized complex is a crystalline substance, and the scanning electron microscopy (SEM) analytic results showed that the synthesized complex is nanorod with an average size of about 40 nm. The thermogravimetry and differential thermal analysis (TG-DTA) result showed that the nanoscale complex has good stability below 449 °C. Photoluminescence spectra (PL) spectra showed that the nanoscale complex emitted characteristic red luminescence of Eu (III) under ultraviolet light.

Keywords: EUROPIUM; FLUORESCENT COMPLEX; NANOROD; PHTHALIC ACID; PVP

Document Type: Research Article

DOI: https://doi.org/10.1166/jnn.2010.2621

Publication date: 2010-05-01

More about this publication?
  • Journal for Nanoscience and Nanotechnology (JNN) is an international and multidisciplinary peer-reviewed journal with a wide-ranging coverage, consolidating research activities in all areas of nanoscience and nanotechnology into a single and unique reference source. JNN is the first cross-disciplinary journal to publish original full research articles, rapid communications of important new scientific and technological findings, timely state-of-the-art reviews with author's photo and short biography, and current research news encompassing the fundamental and applied research in all disciplines of science, engineering and medicine.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more